A Reading List on the Last Election of a Chairman of California's Stem Cell Agency
The last and only contested election for chairperson of the California Institute for Regenerative Medicine (CIRM) occurred in 2011. It was a race that featured haggling tumult on CIRM’s board and politicking at the gubernatorial level.
Below are links to articles on the California Stem Cell Report dealing with the race. Also included are documents posted on the CIRM website. Some of those links may be dead as the result of changes made by CIRM on its website.
The list is not a complete compendium, however, of all the news coverage or CIRM documents. Links within the articles will take you to additional information, including primary source material. The links to items on the California Stem Cell Report, which then was on a different platform, consist of excerpts and headlines from the actual item.
Criteria for the chairmanship
March 22, 2010
CIRM President Alan Trounson has offered in writing his thoughts on the qualities that should be reflected in a person who may succeed Robert Klein as chairman of the $3 billion stem cell research effort next December.
March 4, 2011 -- Outgoing Chair Robert Klein's lengthy memo on the role of the chair.
March 10, 2011
Directors of the California stem cell agency, in sharply divided moves, today said that its next chairman should serve in a part-time capacity in largely an oversight role.
The June 5 and June 6 items below carry verbatim statements from the two candidates that can only be found on the California Stem Cell Report.
June 5, 2011
Los Angeles cardiologist/businesFrank Litvac, a candidate for chair of the $3 billion California stem cell agency, says he regards the job as part-time and says that the chair should not be involved in day-to-day management.
June 6, 2011
In his first appearance before directors of the $3 billion California stem cell agency, bond financier Jonathan Thomas, a candidate for the chairmanship of the agency, stressed his professional background as an investment banker and attorney and his service on government boards.
June 2, 2011
Here is a brief look at the letters of interest submitted to the board of the $3 billion California stem cell agency by two men in pursuit of a six-year appointment as its new chairman.
News Coverage of the Nomination Process
May 24, 2011
Nature magazine today weighed in with its story on the nominations for the new chairman of the $3 billion California stem cell agency.
The latest news coverage of selection of a new leader for California's $3 billion stem cell agency is meager, to say the least.
May 23, 2011
California State Controller John Chiang today nominated Frank Litvack, a "serial entrepreneur" and cardiologist, to become the new chairman of the $3 billion California stem cell agency.
California Gov. Jerry Brown and the state's treasurer, Bill Lockyer, today nominated the head of a Southern California bond investment firm, Jonathan Thomas, as a candidate to become the new chairman of the $3 billion California stem cell agency.
May 18, 2011
Robert Klein, chairman of the $3 billion California Institute for Regenerative Medicine, is backing the head of a Southern California investment firm to succeed him at the helm of CIRM as it pushes aggressively to bring stem cell therapies into the marketplace, according to a reliable source. However, James Harrison, outside counsel to the CIRM board, flatly denied that Klein has endorsed any candidate.
May 19, 2011
A Los Angeles cardiologist who is also described as a "serial entrepreneuer" is under consideration as a possible candidate for chairman of the $3 billion California stem cell agency.
June 20, 2011
California State Treasurer Bill Lockyer today urged his five appointees to the board of the $3 billion state stem cell agency to vote this week for a Los Angeles bond investor as the new chairman of the research enterprise.
June 22, 2011
A strongly worded letter from California state treasurer Bill Lockyer concerning this week's election of a new chairman of the state's $3 billion stem cell agency could be triggering a bit of blowback for the candidate backed by Lockyer.
May 31, 2011
The Consumer Watchdog organization today endorsed a Los Angeles cardiologist as the new chairman of the $3 billion California stem cell agency, declaring that it is time to "correct the agency's dysfunctional management structure."
Endorsement letter from the president of the Genetics Policy Institute supporting Litvack
CIRM executive structure
June 12, 2011
Key leaders of the California stem cell agency have scheduled a 60-minute meeting tomorrow to decide long-standing, thorny matters at the $3 billion enterprise, ranging from the province of the new chairman and the current president to just exactly who is a senior officer of CIRM.
June 14, 2011, CIRM memo summarizing changes in management structure
June 14, 2011, text of new management structure/internal governance policy
April 2, 2011
In case you missed it, The Sacramento Bee editorialized last week about the $3 billion California stem cell agency, deploring its much-criticized, dual-CEO structure and the possibility of a $400,000 salary for a new, part-time chairman.
March 24, 2011
Three top leaders of the California stem cell agency have come up with a plan that they hope will allow CIRM to avoid the wrath of the public when its new chairman is paid a salary that could be seven times the income of an entire, typical California household.
Failed 2010 attempt to find a new chair
Dec. 13, 2010, letter from state Controller John Chiang, who said the process was "fundamentally flawed."
Dec. 15, 2010
Directors of the California stem cell agency today re-elected Robert Klein as chairman of the $3 billion enterprise, culminating a weeks-long flap that included closed-door dealings, allegations of “sleazy” conduct and dubious, last minute financial warnings about CIRM's financial condition.
Dec. 16, 2010
Canadian scientist Alan Bernstein is not necessarily off the table as a candidate to become the next chairman of the $3 billion California stem cell agency, Nature magazine's Web site is reporting today.
Dec. 5, 2010
The Center for Genetics and Society, which has not written much recently about the California stem cell agency, has posted its perspective on the latest events involving the election of a new chair at the $3 billion enterprise.
Dec. 6, 2010
With one day left before Wednesday's meeting of the directors of the California stem cell agency, the public can find much to mull over by reviewing the agenda for the session. But no one will find anything on three matters that have been expunged from CIRM's Web site. They deal with the less than artful attempt by CIRM Chairman Robert Klein to engineer the selection of his successor.
Dec. 5, 2010
A Canadian scientist yesterday pretty much identified a bottom line on the attempt by CIRM Chairman Robert Klein to hand pick his successor at the $3 billion public research agency. In an interview with the Toronto Globe and Mail, Alan Bernstein said the publicity about the machinations “compromises his international reputation and the reputation of the [California] agency.”
Labels: reading list, new chair
Thanks for reading The California Stem Cell Report! Subscribe for free to receive close to all that you need to know about CIRM.